日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reducing Chemotherapy Waiting Times in the Ambulatory Setting of a Tertiary Cancer Centre Using a Design Thinking Approach

运用设计思维方法缩短三级癌症中心门诊化疗等待时间

Jen, Wei-Ying; Chan, Zhi Yao; Lee, Yee Mei; Ng, Noel; Tan, Belinda; Teo, Constance; Wong, Yuet Peng; Chee, Cheng Ean; Chee, Yen-Lin

Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors

患者衍生化身中的合理药物组合设计揭示了蛋白酶体和 CDK 抑制剂对肝细胞癌的有效抑制作用

Jhin Jieh Lim, Lissa Hooi, Yock Young Dan, Glenn K Bonney, Lei Zhou, Pierce K-H Chow, Cheng Ean Chee, Tan Boon Toh, Edward K-H Chow

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

PRL3-zumab 作为免疫疗法抑制表达 PRL3 癌蛋白的肿瘤

Min Thura #, Abdul Qader Al-Aidaroos #, Abhishek Gupta, Cheng Ean Chee, Soo Chin Lee, Kam Man Hui, Jie Li, Yeoh Khay Guan, Wei Peng Yong, Jimmy So, Wee Joo Chng, Chin Hin Ng, Jianbiao Zhou, Ling Zhi Wang, John Shyi Peng Yuen, Henry Sun Sien Ho, Sim Mei Yi, Edmund Chiong, Su Pin Choo, Joanne Ngeow, M

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy

开发一种新的患者来源的异种移植人源化小鼠模型来研究人类特异性肿瘤微环境和免疫疗法

Yue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, Xue Ying Chan, Min Liu, Sue Yee Tan, Yong Fan, Hechuan Yang, Shridhar Ganpathi Lyer, Glenn Kunnath Bonney, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Weiwei Zhai, Jerry Kok Yen Chan, Edward Kai-Hua Chow, Cheng Ean Chee, Guan Huei Lee, Yock Young Dan,